These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12209699)

  • 1. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
    Meric F; Hess KR; Varma DG; Hunt KK; Pisters PW; Milas KM; Patel SR; Benjamin RS; Plager C; Papadopoulos NE; Burgess MA; Pollock RE; Feig BW
    Cancer; 2002 Sep; 95(5):1120-6. PubMed ID: 12209699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
    J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: five-year results with epirubicin and ifosfamide.
    Ottaiano A; De Chiara A; Fazioli F; De Rosa V; Ravo V; Boccia V; Botti G; Petrillo A; Fiore F; Mori S; Mozzillo N; Iaffaioli VR; Apice G
    Anticancer Res; 2002; 22(6B):3555-9. PubMed ID: 12552955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
    Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
    Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
    Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
    Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
    King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome.
    Takeuchi A; Tsuchiya H; Yamamoto N; Hayashi K; Yamauchi K; Kawahara M; Miyamoto K; Tomita K
    Anticancer Res; 2007; 27(5B):3489-95. PubMed ID: 17972506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas.
    Meric F; Milas M; Hunt KK; Hess KR; Pisters PW; Hildebrandt G; Patel SR; Benjamin RS; Plager C; Papadopolous NE; Burgess MA; Pollock RE; Feig BW
    J Clin Oncol; 2000 Oct; 18(19):3378-83. PubMed ID: 11013278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and prognosis of 33 patients with recurrent retroperitoneal soft tissue sarcomas].
    Cai J; Shao Y; Yu H; Chen K; Jiang Y
    Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):671-3. PubMed ID: 11825495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
    Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of soft tissue sarcomas of the hand and foot.
    Lin PP; Guzel VB; Pisters PW; Zagars GK; Weber KL; Feig BW; Pollock RE; Yasko AW
    Cancer; 2002 Aug; 95(4):852-61. PubMed ID: 12209730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative doxorubicin plus ifosfamide in primary soft-tissue sarcomas of the extremities.
    Azzarelli A; Quagliuolo V; Casali P; Fissi S; Montalto F; Santoro A
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S210-2. PubMed ID: 8453700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
    Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
    Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
    Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
    J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
    Ferrari A; Brecht IB; Koscielniak E; Casanova M; Scagnellato A; Bisogno G; Alaggio R; Cecchetto G; Catania S; Meazza C; Int-Veen C; Kirsch S; Dantonello T; Carli M; Treuner J
    Pediatr Blood Cancer; 2005 Aug; 45(2):128-34. PubMed ID: 15852434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.